The Department of Justice will not pursue criminal charges against DuPont over its handling of C8 at Washington Works.
In an email sent to employees yesterday, CEO Chad Holliday said he received word on Friday that the DOJ has completed its 2 1/2 year investigation into the research and use of C8 near Parkersburg, West Virginia.
At issue was whether or not DuPont acted criminally in covering up medical monitoring results which indicated that the manufacturing substance can cross the placenta, thereby contaminating the blood of an unborn baby. The company also shielded evidence of possible birth defects in two of seven babies born to mothers who worked in the Teflon division. Late in 2005, DuPont agreed to a settlement with the EPA worth more than $16 million in fines and environmental projects over the hidden evidence.
Holliday said DuPont will continue to focus on meeting commitments to the EPA’s Voluntary Stewardship Program, which calls for the global phaseout of C8 by 2015.